» Articles » PMID: 34853018

Handheld Chromatic Pupillometry Can Accurately and Rapidly Reveal Functional Loss in Glaucoma

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 2021 Dec 2
PMID 34853018
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Early detection and treatment of glaucoma can delay vision loss. In this study, we evaluate the performance of handheld chromatic pupillometry (HCP) for the objective and rapid detection of functional loss in glaucoma.

Methods: In this clinic-based, prospective study, we enrolled 149 patients (median (IQR) years: 68.5 (13.6) years) with confirmed glaucoma and 173 healthy controls (55.2 (26.7) years). Changes in pupil size in response to 9 s of exponentially increasing blue (469 nm) and red (640 nm) light-stimuli were assessed monocularly using a custom-built handheld pupillometer. Pupillometric features were extracted from individual traces and compared between groups. Features with the highest classification potential, selected using a gradient boosting machine technique, were incorporated into a generalised linear model for glaucoma classification. Receiver operating characteristic curve analyses (ROC) were used to compare the performance of HCP, optical coherence tomography (OCT) and Humphrey Visual Field (HVF).

Results: Pupillary light responses were altered in glaucoma compared with controls. For glaucoma classification, HCP yielded an area under the ROC curve (AUC) of 0.94 (95% CI 0.91 to 0.96), a sensitivity of 87.9% and specificity of 88.4%. The classification performance of HCP in early-moderate glaucoma (visual field mean deviation (VFMD) > -12 dB; AUC=0.91 (95% CI 0.87 to 0.95)) was similar to HVF (AUC=0.91) and reduced compared with OCT (AUC=0.97; p=0.01). For severe glaucoma (VFMD ≤ -12 dB), HCP had an excellent classification performance (AUC=0.98, 95% CI 0.97 to 1) that was similar to HVF and OCT.

Conclusion: HCP allows for an accurate, objective and rapid detection of functional loss in glaucomatous eyes of different severities.

Citing Articles

Differences in the pupillary responses to evening light between children and adolescents.

Hartstein L, LeBourgeois M, Durniak M, Najjar R J Physiol Anthropol. 2024; 43(1):16.

PMID: 38961509 PMC: 11221120. DOI: 10.1186/s40101-024-00363-6.


Basics, benefits, and pitfalls of pupillometers assessing visual function.

Philibert M, Milea D Eye (Lond). 2024; 38(12):2415-2421.

PMID: 38802485 PMC: 11306737. DOI: 10.1038/s41433-024-03151-9.


Chromatic pupillometry for evaluating melanopsin retinal ganglion cell function in Alzheimer's disease and other neurodegenerative disorders: a review.

Romagnoli M, Amore G, Avanzini P, Carelli V, La Morgia C Front Psychol. 2024; 14:1295129.

PMID: 38259552 PMC: 10801184. DOI: 10.3389/fpsyg.2023.1295129.


The Structural Layers of the Porcine Iris Exhibit Inherently Different Biomechanical Properties.

Tan R, Panda S, Braeu F, Muralidharan A, Nongpiur M, Chan A Invest Ophthalmol Vis Sci. 2023; 64(13):11.

PMID: 37796489 PMC: 10561784. DOI: 10.1167/iovs.64.13.11.


Differences in the Pupillary Responses to Evening Light between Children and Adolescents.

Hartstein L, LeBourgeois M, Durniak M, Najjar R bioRxiv. 2023; .

PMID: 37645820 PMC: 10461909. DOI: 10.1101/2023.08.09.552691.


References
1.
McDougal D, Gamlin P . The influence of intrinsically-photosensitive retinal ganglion cells on the spectral sensitivity and response dynamics of the human pupillary light reflex. Vision Res. 2009; 50(1):72-87. PMC: 2795133. DOI: 10.1016/j.visres.2009.10.012. View

2.
Cook C . Glaucoma in Africa: size of the problem and possible solutions. J Glaucoma. 2009; 18(2):124-8. DOI: 10.1097/IJG.0b013e318189158c. View

3.
Rukmini A, Milea D, Baskaran M, How A, Perera S, Aung T . Pupillary Responses to High-Irradiance Blue Light Correlate with Glaucoma Severity. Ophthalmology. 2015; 122(9):1777-85. DOI: 10.1016/j.ophtha.2015.06.002. View

4.
Wride N, Habib M, Morris K, Campbell S, Fraser S . Clinical evaluation of a rapid, pupil-based assessment of retinal damage associated with glaucoma. Clin Ophthalmol. 2009; 3:123-8. PMC: 2709032. View

5.
Bramley T, Peeples P, Walt J, Juhasz M, Hansen J . Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol. 2008; 126(6):849-56. DOI: 10.1001/archopht.126.6.849. View